PIC/S has published the revised PIC/S Recommendations on Qualification and Validation (PI 006-4). The document supersedes PI 006-3 and will enter into force on 1 October 2026. This is an important operational development for GMP sites: PI 006-4 brings together recommendations covering the Validation Master Plan (VMP), qualification of facilities and equipment, process validation, selected additional topics and cleaning validation in one substantially expanded document.
PI 006-4 is published by PIC/S as a guidance document for inspectors. It is not a replacement for the applicable legal GMP framework or for the PIC/S GMP Guide / EU GMP requirements. Its stated purpose is to provide additional guidance and a training resource for GMP inspectors and industry, supplementing the basic qualification and validation principles in Annex 15 to the PIC/S and EU Guide to GMP. Manufacturers should therefore distinguish carefully between binding requirements applicable in their jurisdiction and the inspection-facing expectations and recommendations set out in PI 006-4.
What PIC/S has changed
The previous document, Recommendations on validation master plan, installation and operational qualification, non-sterile process validation, cleaning validation (PI 006-3), entered into force on 25 September 2007. PIC/S states that PI 006-4 updates and renames that document following the 2015 revision of Annex 15. The new publication is broader in scope and more explicitly lifecycle-oriented.
Its contents now cover:
- general qualification and validation principles, including change control, organisation and Quality Risk Management (QRM);
- the VMP;
- prequalification and qualification stages for facilities, supporting utilities, equipment and systems, including Design Qualification (DQ), Installation Qualification (IQ), Operational Qualification (OQ) and Performance Qualification (PQ);
- process validation, including prospective validation, concurrent validation, approaches supporting initial commercialisation, ongoing (or continued) process verification (OPV) and revalidation;
- verification of transportation, validation of packaging for solid dose products, qualification of supporting utilities and validation of test methods; and
- an expanded cleaning validation section covering documentation, personnel, equipment, microbiological aspects, visual inspection, sampling, detergents, analytical methods, limits and maintenance of a validated cleaning process.
The scope expressly says that the principles apply equally to the manufacture of APIs, intermediates and finished dosage forms. PI 006-4 does not cover validation of GMP-impacting computerised systems, which remains covered by Annex 11, nor does it address analytical method validation in depth. It also identifies specialised PIC/S guidance, such as PI 007 for aseptic-process validation, as remaining relevant.
Key messages for senior GMP leadership
Qualification and validation are lifecycle activities
PI 006-4 reinforces that qualification and validation should be conducted using a lifecycle approach, with methodology, documentation and effort appropriate to the lifecycle stage of the facility, supporting utility, equipment, system or process. The document also emphasises continuing reassessment to incorporate modern concepts, technology and statistical tools.
For management, this is a prompt to test whether validation governance is still focused mainly on project execution and batch-release milestones. A credible lifecycle model needs a visible connection between commissioning and qualification, routine monitoring, maintenance and calibration, deviations, CAPA, periodic review, change control, OPV and requalification or revalidation decisions.
The VMP must work as a controlled management instrument
PI 006-4 describes the VMP as the risk-based, scientifically sound template from which qualification and validation activities are developed. It should provide an overview of the programme, its organisation, content and planning, including an inventory of facilities, supporting utilities, equipment, systems and processes requiring qualification or validation.
The VMP should cover the lifecycle review of the state of control of previously qualified or validated assets and processes. PIC/S also sets out detailed content expectations: responsibilities, an approach to worst case, the validation inventory and status, acceptance criteria, governing SOPs, scheduling, change control, deviation management and data integrity. The guidance expects management approval and regular review, with updating following relevant changes.
GuideGxP recommendation: do not treat this as a document-format exercise. Use the gap assessment to establish whether the VMP is an accurate, approved portfolio view of actual validation commitments, priorities, overdue work, dependencies and residual risks. The inventory, change-control register and CAPA system should reconcile.
Change control must trigger proportionate validation action
PI 006-4 presents change control as a key mechanism for maintaining qualified and validated status. It recommends use of QRM to evaluate potential effects on product quality, the Pharmaceutical Quality System (PQS), documentation, qualification and validation status, regulatory status, calibration and maintenance. It also describes appropriate cross-functional oversight, Quality Unit involvement and tracking of actions to completion.
The document calls for effectiveness evaluation where appropriate and for a documented justification when it is not required. It notes that change data should be tracked in a way that enables trending by product, department or production line.
GuideGxP recommendation: sample closed change controls for the last 12 months, especially automation changes, utility modifications, supplier-material changes, cleaning-procedure changes and process parameter changes. Check whether the rationale for “no requalification”, “no revalidation” or “no effectiveness check” is scientifically justified, approved and consistent with the VMP.
Specific workstreams to assess before 1 October 2026
| Workstream | PI 006-4 focus | Practical gap-assessment question |
|---|---|---|
| Qualification | Traceability from URS and DQ through IQ, OQ and PQ; formal progression between stages; evidence of ongoing control. | Can the site demonstrate clear requirements traceability and justified release to each next stage? |
| Process validation | Scientific process understanding, pre-defined sampling and acceptance criteria, suitable statistical methods and OPV. | Are validation protocols and OPV plans aligned to actual CQAs, CPPs, variability and lifecycle knowledge? |
| Cleaning validation | Risk-based scope, hold times, campaign length, failures, sampling, analytical capability, limits and continued control. | Does the programme address dirty and clean hold times, supplier-related material variability and recurring cleaning failures? |
| Data integrity | Data governance throughout qualification and validation; independent confirmation of data integrity requirements in reports. | Are original records, review evidence, audit trails and report conclusions demonstrably complete and attributable? |
Qualification: retain flexibility, prove fitness for intended use
PI 006-4 recognises that scientifically and engineering-based approaches using different terminology, such as ASTM E2500, may be appropriate. However, the central expectation remains unchanged: the manufacturer must demonstrate that facilities, supporting utilities, equipment and systems perform as expected and are fit for purpose.
The document explicitly links URS, DQ, IQ, OQ and PQ. It describes formal authorisation to move to the next qualification stage, with conditional progression only where unresolved acceptance criteria or deviations have been assessed and documented as having no significant impact on the next activity. It also expects procedures for operation, maintenance, calibration and cleaning, and appropriate employee training, to support the controlled state.
Process validation: strengthen the link between knowledge, statistics and routine verification
The process-validation section places substantial weight on process understanding and control strategy. Before prospective validation begins, PI 006-4 lists prerequisites including knowledge of the Quality Target Product Profile (QTPP), critical quality attributes (CQAs), critical process parameters (CPPs), critical material attributes (CMAs), relevant development, scale-up and technology-transfer reports, qualified systems and validated methods.
It also expects sampling design, sample numbers, data handling and acceptance criteria to be defined and justified before the exercise. Where statistical approaches are used, the guidance says that they should be scientifically sound, suited to the risk to patient health and involve both subject matter experts and statisticians. Both intra-batch and inter-batch variability should be considered.
GuideGxP recommendation: reassess legacy validation rationales that rely on convention rather than product and process knowledge. In particular, make sure that initial validation, OPV and annual product quality review arrangements produce an integrated view of process capability and emerging loss of control.
Cleaning validation: no tolerance for repeated “test until clean” practice
PI 006-4 gives cleaning validation a dedicated and detailed section. It expects risk assessment to determine the scope, depth, breadth and effort of the programme. It calls for evidence supporting maximum dirty hold time, clean hold time and campaign length. It also requires cleaning failures during or after validation to be recorded, investigated and assessed for their impact on validation and verification.
Most notably, the document states that continued cleaning failures and/or repeated cleaning and testing until acceptable results are achieved are not acceptable. Where intermittent failure occurs, manufacturers should implement remediation, which may include improving procedures, reassessing risk or introducing further mitigation such as equipment or facility dedication.
GuideGxP recommendation: make recurring cleaning deviations a management-review topic. Confirm that visual inspection failures, recovery-study assumptions, analytical method capability, worst-case product selection, bracketing logic and campaign assessments have a current scientific rationale.
Recommended implementation plan
- Assign accountable ownership. Establish a cross-functional PI 006-4 review team led by QA and Validation, with Manufacturing, Engineering, QC, supply chain and Regulatory Affairs participation.
- Map PI 006-4 against the PQS. Assess the VMP, governance procedures, change control, deviations, CAPA, data governance, asset lifecycle management and product lifecycle management—not only validation SOPs.
- Prioritise high-risk gaps. Focus first on shared equipment, complex utilities, critical processes, new technology, products with constrained process capability, cleaning failure history and upcoming regulatory commitments.
- Convert gaps into controlled actions. Define owners, risk-based due dates, interim controls, required protocol/report updates and effectiveness measures. Use formal change control where changes affect the validated state.
- Prepare inspection-ready rationale. Ensure that decisions on scope, worst case, sample design, acceptance criteria, requalification, revalidation and cleaning limits can be explained from documented science and QRM.
Conclusion
PI 006-4 does not prescribe a single validation model. It instead provides a consolidated, detailed statement of PIC/S recommendations intended to support GMP-compliant validation programmes. Its practical impact will be greatest where validation systems have become fragmented: a static VMP, weak traceability from requirements to testing, change controls without lifecycle follow-through, or cleaning programmes that normalise repeated failure.
With the document entering into force on 1 October 2026, the appropriate response is a proportionate and evidence-led gap assessment now. The outcome should be more than revised SOP titles: it should show that the site’s qualification and validation programme remains scientifically justified, actively governed and capable of sustaining a state of control.
